RAISED LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN CARDIAC TRANSPLANT PATIENTS
Enzyme immunoassay is used to probe serum and plasma levels of tumor-necrosis factor-alpha (TNFα) in human heart transplant patients during the first few months post-transplantation. Detectability of TNFα was increased by heat-pretreatment of serum (56°C for 30 minutes), in order to inactivate inhib...
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Published: |
1993
|
_version_ | 1797078690606088192 |
---|---|
author | Sabokbar, A Horton, J Bowler, K Manning, R Meager, A Dark, J |
author_facet | Sabokbar, A Horton, J Bowler, K Manning, R Meager, A Dark, J |
author_sort | Sabokbar, A |
collection | OXFORD |
description | Enzyme immunoassay is used to probe serum and plasma levels of tumor-necrosis factor-alpha (TNFα) in human heart transplant patients during the first few months post-transplantation. Detectability of TNFα was increased by heat-pretreatment of serum (56°C for 30 minutes), in order to inactivate inhibitors of the immunoassay present in the sera. In EDTA-treated plasma samples such treatment was not necessary, thus suggesting the possible involvement of complement in such inhibition. Compared with samples from control (healthy) volunteers, transplant patients frequently displayed elevated levels of TNFα, especially in the first few weeks post-transplantation. However, increased cytokine levels did not correlate with histologically (biopsy)-determined rejection episodes. We were unable to detect interleukin-6 (IL-6) in plasma samples of heart transplant patients. |
first_indexed | 2024-03-07T00:35:20Z |
format | Journal article |
id | oxford-uuid:8132fd60-1ed2-4990-837e-3a09898e4eff |
institution | University of Oxford |
last_indexed | 2024-03-07T00:35:20Z |
publishDate | 1993 |
record_format | dspace |
spelling | oxford-uuid:8132fd60-1ed2-4990-837e-3a09898e4eff2022-03-26T21:28:48ZRAISED LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN CARDIAC TRANSPLANT PATIENTSJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8132fd60-1ed2-4990-837e-3a09898e4effSymplectic Elements at Oxford1993Sabokbar, AHorton, JBowler, KManning, RMeager, ADark, JEnzyme immunoassay is used to probe serum and plasma levels of tumor-necrosis factor-alpha (TNFα) in human heart transplant patients during the first few months post-transplantation. Detectability of TNFα was increased by heat-pretreatment of serum (56°C for 30 minutes), in order to inactivate inhibitors of the immunoassay present in the sera. In EDTA-treated plasma samples such treatment was not necessary, thus suggesting the possible involvement of complement in such inhibition. Compared with samples from control (healthy) volunteers, transplant patients frequently displayed elevated levels of TNFα, especially in the first few weeks post-transplantation. However, increased cytokine levels did not correlate with histologically (biopsy)-determined rejection episodes. We were unable to detect interleukin-6 (IL-6) in plasma samples of heart transplant patients. |
spellingShingle | Sabokbar, A Horton, J Bowler, K Manning, R Meager, A Dark, J RAISED LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN CARDIAC TRANSPLANT PATIENTS |
title | RAISED LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN CARDIAC TRANSPLANT PATIENTS |
title_full | RAISED LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN CARDIAC TRANSPLANT PATIENTS |
title_fullStr | RAISED LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN CARDIAC TRANSPLANT PATIENTS |
title_full_unstemmed | RAISED LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN CARDIAC TRANSPLANT PATIENTS |
title_short | RAISED LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN CARDIAC TRANSPLANT PATIENTS |
title_sort | raised levels of tumor necrosis factor alpha tnf alpha in cardiac transplant patients |
work_keys_str_mv | AT sabokbara raisedlevelsoftumornecrosisfactoralphatnfalphaincardiactransplantpatients AT hortonj raisedlevelsoftumornecrosisfactoralphatnfalphaincardiactransplantpatients AT bowlerk raisedlevelsoftumornecrosisfactoralphatnfalphaincardiactransplantpatients AT manningr raisedlevelsoftumornecrosisfactoralphatnfalphaincardiactransplantpatients AT meagera raisedlevelsoftumornecrosisfactoralphatnfalphaincardiactransplantpatients AT darkj raisedlevelsoftumornecrosisfactoralphatnfalphaincardiactransplantpatients |